CytomX Therapeutics Inc (CTMX)

16.97
0.20 1.20
NASDAQ : Health Care
Prev Close 17.17
Open 17.19
Day Low/High 16.40 / 17.81
52 Wk Low/High 9.01 / 24.68
Volume 385.56K
Avg Volume 245.70K
Exchange NASDAQ
Shares Outstanding 36.57M
Market Cap 662.25M
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Stocks move mostly higher on Monday morning as a hearing on Russia's involvement in the U.S. election begins on Capitol Hill.

Biotech Premarket Movers: CytomX, Aevi, Esperion

Biotech Premarket Movers: CytomX, Aevi, Esperion

CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday.

CytomX Soars on Bristol-Myers Partnership

CytomX Soars on Bristol-Myers Partnership

Shares of the biotech, which researches cancer drugs, were up nearly 30% ahead of market's open.

Stock Futures Slip After G20 Meeting Raises Fears of Protectionism

Stock Futures Slip After G20 Meeting Raises Fears of Protectionism

Stock futures move mostly lower on Monday after the weekend's G20 meeting raises fears over protectionist attitudes among the world's largest economies.

CytomX Therapeutics Announces Teleconference And Webcast To Provide Corporate Update

CytomX Therapeutics Announces Teleconference And Webcast To Provide Corporate Update

Teleconference Scheduled for Monday, March 20, 2017 at 8:00 a.m. ET

CytomX Announces Selection By Bristol-Myers Squibb Of First Clinical Candidate Probody From Collaboration

CytomX Announces Selection By Bristol-Myers Squibb Of First Clinical Candidate Probody From Collaboration

CTLA-4 Probody Moves to IND-Enabling Studies

CytomX Announces Fourth Target Selection By Bristol-Myers Squibb Under Strategic Oncology Collaboration

CytomX Announces Fourth Target Selection By Bristol-Myers Squibb Under Strategic Oncology Collaboration

Triggers $15 Million Milestone Payment to CytomX

Relative Strength Alert For CytomX Therapeutics

Relative Strength Alert For CytomX Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AER, AIMC, ALLY, BKU, PH, VSH Downgrades: CRAY, HMSY, OPK, SOHO, SONS, TRNC, TSRI, UTSI Initiations: CTMX, DERM Read on to get TheStreet Quant Ratings' detailed report:

These 5 Stocks Are Ready for Breakouts

These 5 Stocks Are Ready for Breakouts

Here's a look at how to trade five stocks that are poised to break out and trade higher from current levels.

7 Stocks Under $10 to Trade for Big Post-Brexit Gains

7 Stocks Under $10 to Trade for Big Post-Brexit Gains

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

CytomX Therapeutics Enters Oversold Territory (CTMX)

CytomX Therapeutics Enters Oversold Territory (CTMX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

CytomX Therapeutics is Now Oversold (CTMX)

CytomX Therapeutics is Now Oversold (CTMX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.